Pia Raanani
Petah Tiqwa, M, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 232 publications
Cardiac Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With First-Line Ibrutinib-Venetoclax.
Journal: European journal of haematology
Published: June 17, 2026
Chronic Lymphocytic Leukemia (CLL)-Derived Extracellular Vesicles (EVs) Modulate Monocytes to Become CLL-Supportive Cells.
Journal: International journal of molecular sciences
Published: April 07, 2026
Acta Haematologica in the Era of Artificial Intelligence.
Journal: Acta haematologica
Published: March 18, 2026
Thrombosis in Low-Risk Polycythemia Vera: Insights From a Large Real-World Cohort.
Journal: Hematological oncology
Published: January 20, 2026
Low-normal immunoglobulin suggests monoclonal B-cell lymphocytosis and constitutional CLL susceptibility: a dual-mechanism analysis.
Journal: Leukemia
Published: January 19, 2026
Post-Transplant Lymphoproliferative Disorder following Heart Transplantation Presenting as a Retroperitoneal Plasmacytoma: A Case Report and Review of the Literature.
Journal: Acta haematologica
Published: November 06, 2025
Reduced number of endothelial progenitor cells in adult patients with beta thalassemia major.
Journal: Annals of hematology
Published: October 05, 2025
Glucose-6-phosphate dehydrogenase deficiency is associated with improved survival in patients with acute myeloid leukemia treated with venetoclax and azacitidine.
Journal: Cancer
Published: October 03, 2025
High Implementation Adherence to Lenalidomide in Multiple Myeloma.
Journal: Cancers
Published: September 27, 2025
K-562 Extracellular Vesicles Partially Protect Intact Cells from Oxidative Stress and Provide Limited Resistance to Imatinib.
Journal: Current issues in molecular biology
Published: June 30, 2025
Last Updated: 09/26/2026